Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Javelin, Precision Pharma Sign Supply Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Javelin, Precision Pharma Sign Supply Pact

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Javelin Pharmaceuticals, Inc. has signed a commercial supply agreement with Precision Pharma Services. Under the agreement, Precision will manufacture vials of Javelin’s injectable Dyloject product for use in European markets, pending regulatory approval. The agreement has a two-year, renewable term and includes minimum purchase and production requirements.

“This agreement is an important step forward in growing Javelin’s manufacturing infrastructure in anticipation of initial product sales later this year in Europe,” said Michael Moshman, Javelin’s vice president for clinical and commercial manufacturing. “Working with Precision Pharma will enable us to marshal the resources to meet future demand for Dyloject as we begin commercializing this promising analgesic with its launch in the UK in 2007.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics